[1]
Tekieli, B. et al. 2026. GLP-1 AND DUAL GLP-1/GIP RECEPTOR AGONISTS AS NEUROPROTECTIVE AGENTS: MECHANISMS, CLINICAL EVIDENCE, AND TRANSLATIONAL PERSPECTIVES. International Journal of Innovative Technologies in Social Science. 4, 3(51) (Sep. 2026). DOI:https://doi.org/10.31435/ijitss.3(51).2026.6110.